Veradermics Incorporated
MANE
NYSE
IPO2026
about MANE
Veradermics Incorporated specializes in developing advanced biotechnology solutions, including a cutting-edge gene-editing platform designed to address degenerative conditions such as arthritis and multiple sclerosis.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $47.99 | $49.98 | $47.73 | $1.7B | 115.72K |